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Stent attachment site–related endoleakage
after stent graft treatment: An in vitro
study of the effects of graft size, stent
type, and atherosclerotic wall changes
Geert Willem H. Schurink, MD, Nico J.M. Aarts, MD, Jary M. van Baalen, MD,
Leo J. Schultze Kool, MD, and J. Hajo van Bockel, MD, Leiden, The Netherlands
Objective: Perigraft endoleakage is a major complication of the endovascular treatment
of abdominal aortic aneurysms. The factors that cause this form of endoleakage are not
completely identified. The effect of sizing of the prosthesis in combination with either
self-expandable or balloon-expandable stents is evaluated in this study. Further, the
influence of atherosclerotic changes on endoleakage is evaluated.
Methods: Eight human abdominal aortas were assessed macroscopically at 11 sites for the
presence of atherosclerotic changes with intravascular ultrasound scanning (IVUS) and
with computed tomography (CT). Five aortas were placed in in vitro circulation with
physiologic parameters. After the determination of the proximal and distal landing site of
the stent graft, the diameter and surface measurements of the cross sections were taken.
The stent graft diameters were chosen from 4-mm undersizing to 6-mm oversizing, both
for Gianturco stent grafts (William Cook Europe A/S, Bjaeverskov, Denmark) and for
Palmaz stent grafts (Cordis/Johnson & Johnston Co, Warren, NJ). After placement of
the stent graft, the diameter and surface measurements of the aortic cross section were
determined at the proximal and distal stent attachment sites. The presence and size of the
folds at the stent attachment site and the interface with the aortic wall were determined
with IVUS and angioscopy. Endoleakage was evaluated with angiography. After angio-
plasty of the stent attachment site, IVUS, angioscopy, and angiography were repeated.
Results: Regarding atherosclerotic changes of the aortic wall, the correlations between clin-
ical impression and CT, clinical impression and IVUS, and CT and IVUS were high (r =
0.77, r = 0.79 and r = 0.79, respectively). For the Gianturco stent grafts, no significant
relationship existed between the diameters measured before and after stent graft place-
ment, leading to great differences in intended and achieved oversizing. The achieved over-
sizing was less in the case of minimal atherosclerotic changes of the aortic wall. The
Gianturco stent graft followed the aortic wall closely during the heart cycle. The sizes of
the folds of the fabric were clearly correlated with the achieved oversizing (r = 0.83; P =
.04) and the grade of endoleakage (r = 0.88; P = .022). Angioplasty after stent graft place-
ment had no effect on the diameter and the grade of endoleakage. Palmaz stent grafts did
not follow the aortic wall during the heart cycle. A significant correlation existed between
oversizing and both space between aortic wall and stent graft (r = –0.88; P = .02) and
grade of endoleakage (r = 0.84; P = .036). Grade of endoleakage in the Palmaz stent graft
group was less than in the Gianturco stent graft group.
Conclusion: With the use of Gianturco stents, a great difference between intended and
achieved oversizing is accomplished. The atherosclerotic changes of the aortic wall possi-
bly affect this finding. The configuration of the Gianturco stent results in the formation
of fold in the case of oversizing, which is associated with endoleakage. However, the self-
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Endoleakage is a complication associated with
endoluminal vascular grafts. It is defined by the per-
sistence of blood flow outside the lumen of the
endoluminal graft but within an aneurysmal sac or
adjacent vascular segment being treated with the
graft. In the treatment of abdominal aneurysms,
endoleakage can arise at the proximal and distal stent
attachment sites, through lumbar arteries or the
inferior mesenteric artery, or through graft-to-graft
connections or graft defects.1
Most of these endoleaks have aortic inflow and
originate from the proximal stent attachment site.2
The development of perigraft endoleakage is affected
by the length and shape of the healthy arterial seg-
ment at the stent attachment site, the presence of
thrombus or calcifications at this location, the sizing
of the prosthesis, and the type of stent used. Most
clinicians use a moderate degree of oversizing to
compensate for inaccurate measurements and future
dilation of the arterial segment.3 Choosing a stent
graft diameter that is too small can cause stent attach-
ment site endoleaks. Also, with dilation of the aorta
over time, risk of distal stent graft migration exists.
Oversizing of the prosthesis may lead to folding
of the graft, with the possibility of perigraft endoleak-
age. In addition, the configuration of the stent after
deployment may influence whether or not folding
will lead to endoleakage.
The objective of this study was to evaluate the
effects of the following variables on stent graft/aor-
tic interface and perigraft endoleakage: sizing of the
stent graft, the type of stent, and the characteristics of
the aortic wall. Further, the agreement between
diameter and surface measurements were studied in
consideration of stent graft sizing with automatic
contour detection systems in the future. Also, the
agreement on severity of atherosclerotic wall changes
between clinical impression, intravascular ultrasound
scanning (IVUS), and computed tomography (CT)
was studied.
MATERIAL AND METHODS
Aortic wall evaluation. Eight human abdomi-
nal aortas, from the level of the diaphragm to the
iliac bifurcation, were obtained at autopsy, after the
approval of the hospital medical ethical committee.
The evaluation of the aortic wall was performed
macroscopically with CT and IVUS. Evaluation was
performed at 11 clinically relevant locations by two
observers (G.S. and N.A.) simultaneously: the aorta
above the celiac artery, the suprarenal aorta, the first
3 cm of the infrarenal aorta, the remaining infrarenal
aorta, the aortic bifurcation, and the right iliac
artery. The ostium of the celiac artery, the superior
mesenteric artery, the renal arteries, and the inferior
mesenteric artery were all scored separately.
The aortic wall at each location was classified
with the following ordered scoring system as pro-
posed by Malina4: I, nonatherosclerotic; II, soft inti-
mal thickening; III, calcified plaques engaging part
of the aortic circumference; IV, circumferentially
located calcified plaques; and V, completely calcified
(incompressible) aorta.
The scoring of the clinical impression was done
with palpation. CT scanning was performed for all the
aortas with 3-mm collimation width and 1:1 pitch
(Philips Tomoscan AV, Philips Medical Systems, Best,
The Netherlands). Subsequently, all the aortas were
analyzed in water with IVUS (ClearViewUltra,
SCIMED/Boston Scientific Corporation, Maple
Grove, Minn) with a Sonicath Ultra, 6F, 12.5-MHz
imaging catheter (Meditech/Boston Scientific
Corporation, Watertown, Mass). Clinical impression,
IVUS, and CT were performed on the same day, but
the scoring of the CT and IVUS images was done on
separate days to exclude influencing of results by pre-
vious outcome.
Evaluation of prosthesis sizing. The experi-
ments were performed in in vitro circulation with
physiologic parameters, as for pressure, flow, flow
velocity, and output. The model existed of an artifi-
cial heart, driven by an artificial pneumatic heart dri-
ver, a tubing system, a peripheral resistance, and a
collecting system. The design and parameters of this
circulation have been previously described by our
group.5 In this study, saline solution was used as per-
fusate to enable evaluation with angioscopy.
Two series of stent grafts were created. First, five
stent grafts were created with 16-mm to 24-mm
diameters (2-mm steps), with a Gianturco-Z stent
(William Cook Europe A/S, Bjaeverskov, Denmark)
sutured to the proximal and distal end of the pros-
thesis with approximately 20 polytetrafluoroethyl-
ene sutures. For the prostheses with diameters of 16
expandable character of the stent leads to a close relation to the aortic wall during the
heart cycle, and this may possibly accommodate future aortic neck dilation. The Palmaz
stent grafts do not follow the aortic wall during the heart cycle, but they do lead to bet-
ter interface between the graft and the aortic wall, which results in less endoleakage. 
(J Vasc Surg 1999;30:658-67.)
mm and 18 mm, a Gianturco-ZV-20-25 stent (max-
imal diameter, 20 mm; length, 25 mm) was used,
and for the larger diameters, a Gianturco-ZV-30-25
stent (maximal diameter, 30 mm; length, 25 mm)
was used. Hooks and barbs had been removed to
enable the repeated use of stent grafts and aortas.
Secondly, the same range of five stent grafts was cre-
ated with Palmaz P4014 stents (Cordis/Johnson &
Johnston Co, Warren, NJ), fixed with four polyte-
trafluoroethylene sutures at the proximal end.
Ultra-thin polyethylene terephthate graft materi-
al (Meadox-Boston Scientific Corporation) was used
in both series of stent grafts. Each stent graft had a
length of 5 cm and an uncovered stent part of 1 cm
at each end. The stent grafts were not preclotted and
had a water permeability of 140 mL/cm2/min (at
120 mm Hg).
After ligation of the side branches, the aorta was
positioned in the artificial circulation and submerged
in a basin with water. The aorta was checked for leak-
age during circulation. The IVUS catheter was intro-
duced through a side port in the tubing distal to the
aorta. The diameter of the aorta was measured at the
planned proximal and distal stent attachment site of
the stent graft. In the case of an oval aortic cross sec-
tion, the smallest diameter of the cross section was
considered to be the real diameter.6 The diameter of
the inserted stent graft was chosen in such a way
that, at the end of the experiments, the whole range,
from 2-mm undersizing to 6-mm oversizing (with 2-
mm steps), for both Gianturco and Palmaz stents
was covered. 
The self-expandable stent grafts were introduced
with fluoroscopy over a guidewire through a 22F
modified Chuter delivery device (William Cook
Europe A/S, Bjaeverskov, Denmark). The balloon-
expandable stent grafts were introduced with fluo-
roscopy over a guidewire and mounted on an angio-
plasty balloon (Cordis Europe N.V., Roden, The
Netherlands). The stent grafts with up to 20-mm
diameters were deployed with 4-cm, 20-mm bal-
loons, and the bigger stent grafts were deployed
with 4-cm, 25-mm balloons. The distal Palmaz stent
was introduced separately over a guidewire and posi-
tioned approximately at 1 cm below the proximal
stent and was deployed with the same balloon as was
the proximal stent.
After the deployment of the stent graft, the
diameter of the aorta was determined at the identi-
cal site as before stent graft insertion. During the
IVUS imaging, we looked for folding of the pros-
thesis at both stent attachment sites, for movement
of aorta and stent during the heart cycle, and for
space between the stent graft and the aorta wall. The
number and size of the folds and the extent of the
space between the graft and the aorta were record-
ed. Angioscopy (Baxter, Health Care Corporation,
Irvine, Calif) was performed from the proximal and
distal end, evaluating the amount of folding of the
prosthesis and for the evaluation of the stent
graft/aortic interface.
Subsequently, digital subtraction angiography
(DSA; Integris V3000, Philips Medical System, Best,
The Netherlands) was performed with on-hand
bolus contrast admission of 20 mL (Isopaque cysto,
Byk, Milano, Italy). DSA was repeated after the
opening of an aortic side branch at the middle part
of the stent graft. Endoleakage was classified in the
following five groups, according to the perception of
two observers (G.S. and N.A.), simultaneously: I,
none; II, minor; III, mild; IV, major; and V, gross.
In the presence of folds or space between the stent
graft and the aortic wall, an angioplasty was per-
formed. This angioplasty was performed with a less
than 3-mm oversized balloon as compared with the
smallest of either graft or aorta during 15 seconds with
1-atm pressure. The purpose of the angioplasty was to
optimize the aorta/stent graft alignment, rather than
to perform dilation of the aorta. Thereafter, measure-
ments with IVUS, angioscopy, and DSA, with closed
and open side branch, were repeated.
The IVUS images were recorded on video. After
the experiments were completed, all the diameters
and circumferences of the proximal and distal stent
attachment site before and after stent graft place-
ment and after angioplasty were measured meticu-
lously, as was the number and size of folds and space
between stent graft and aortic wall.
The angioscopic images also were recorded on
video. The number of folds and stent graft/aortic
interface were determined from video after the
experiments were finished.
Statistical analysis. SPSS 7.5 for Windows
(SPSS, Inc, Chicago, Ill) was used for the statistical
calculations. An evaluation of diameter and surface
data was done with paired sample t test. The corre-
lation coefficients were calculated with Spearman
rank correlation. Statistical significance was defined
as a P value of less than .05.
RESULTS
Aorta wall characteristics. A total of 11 differ-
ent sites in eight ex vivo human aortas were scored
for atherosclerotic wall changes with palpation and
with both CT and IVUS, resulting in a total of 264
measurements. Twenty of the potential 264 mea-
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surements could not be determined. During scoring
with palpation, the inferior mesenteric artery (IMA)
could not be identified in three cases of aneurysmal
changes in the infrarenal aorta. CT results could not
identify the IMA in five cases, and the IMA could
never be identified with IVUS. In an aorta with
much thrombus mass over its total length, the IVUS
could not identify any side branch, leading to 12
missing cases in the IVUS group. Correlations
between clinical impression and CT, clinical impres-
sion and IVUS, and CT and IVUS were high, with
correlation coefficients of 0.77, 0.79, and 0.79,
respectively (P < .001), and with a mean difference
of 0.20, 0.24, and 0.03 points, respectively, on the
ordered, five-point scoring system. Thus, there was
no systematic difference between the measurements.
The direct infrarenal segment in the eight aortas,
especially important for endovascular treatment of
aortic aneurysms as proximal stent attachment site,
never had circumferentially located calcified plaques
(grade IV) nor was completely calcified (grade V).
In contrast, the aorta bifurcation was classified as
grade IV in 13 of the 24 observations by the three
techniques (54%) and as grade V in two of the 24
observations (8%).
Diameter versus surface measurements. Thirty-
seven paired measurements of aortic diameter and sur-
face could be compared. Not surprisingly, a significant
correlation existed between the diameter and the sur-
face measurements of an IVUS aorta cross section (r =
0.94; P < .0001). However, if the measured surface
was used to calculate the aortic diameter (surface =
1⁄2π[diameter]2), the mean difference between the cal-
culated diameter and the measured diameter was 0.36
mm (range, –1 mm to +2 mm; standard deviation,
0.78 mm). The limits of agreement between both
methods of determination of the aortic diameter are
shown in Fig 1.
Self-expendable stent grafts. Four Gianturco
stent grafts were inserted in three aortas so that
eight stent attachment sites could be evaluated. The
difference between aortic diameter and graft diame-
ter ranged from 3-mm undersizing to 5-mm over-
sizing equally distributed. The changes in the diam-
eter of the aortic cross section at the stent site are
given in Tables I and II, in both millimeters and per-
centage, respectively. Percentile change is given in
addition to the change in millimeters because a cer-
tain change in diameter or surface in a small aorta is
proportionally bigger than the same change in a
larger aorta. There was no correlation between the
diameter of the aorta before and after stent graft
placement (r = 0.49; P = .21). For the same reason
as mentioned previously, differences in diameter and
surface of prosthesis and aorta were calculated in
millimeters and percentage. This resulted in a sub-
stantial difference between the intended and
achieved undersizing or oversizing of the stent graft
as compared with the aortic diameter (Fig 2). The
IVUS results showed that the correlation between
diameters directly after stent graft delivery and after
angioplasty was statistically significant (r = 0.78; P =
.02). The characteristics of the aortic wall appeared
to influence the change in diameter after stent graft
delivery. In the CT grade II aorta (soft intimal thick-
ening; n = 4), the diameter change varied from –1 to
Fig 1. Limits of agreement, according to Bland and Altman,20 of difference between calculated
diameter (from aortic surface) and measured aortic diameter versus mean of both diameters.
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+6 mm, whereas for the CT grade III aorta (calcified
plaques engaging part of the aorta circumference; n
= 4), the diameter changed from –4 mm to +1 mm
(Fig 3).
The evaluation results of the stent attachment sites
with IVUS and angioscopy showed a mean number of
folds of 1.6 (range, 0 to 3) and 2.6 (range, 0 to 4),
respectively, after stent graft deployment, and of 1.5
(range, 0 to 4) and 2.8 (range, 1 to 4), respectively,
after angioplasty. There was a significant correlation
between the number of folds that were detected with
IVUS and with angioscopy after stent graft deploy-
ment (r = 0.86; P = .007) and after angioplasty (r =
0.72; P = .03). The mean diameter of the biggest fold
per stent attachment site measured with IVUS was 3
mm (range, 2 to 5 mm) after stent graft deployment
and 2 mm (range, 0 to 5 mm) after angioplasty. A
visual inspection of the movement of the stent graft
and aortic wall with angioscopy showed that the
Gianturco stent followed the pulsatile movement of
the aortic wall closely during the heart cycle. The
folds were bigger during the diastolic phase than dur-
ing the systolic phase.
There was a significant relation between the size of
the biggest fold and the percentage of actual undersiz-
ing/oversizing of the stent grafts directly after
Gianturco stent graft placement (Fig 4). No endoleak-
age was visualized during DSA during any experiment.
However, leakage of contrast was observed in all cases
if a previously ligated aortic side branch at the middle
section of the aorta, covered with stent graft, was re-
opened. It was not possible to differentiate between
proximal and distal stent attachment site as the source
of the perigraft endoleak. The grade of endoleakage
was significantly related to the size of the biggest fold
after stent graft deployment (Fig 5). After angioplasty,
the grade of endoleakage was correlated to the differ-
ence in diameter between graft and aorta, both for dif-
ference in millimeters (r = 0.79; P = .02) and for per-
centile difference (r = 0.76; P = .03). As compared
with the situation immediately after stent graft deploy-
ment, no change in the grading of endoleakage was
observed after angioplasty had been performed.
Balloon-expandable stent grafts. Three Palmaz
stent grafts were deployed in two aortas. Thus, six
stent attachment sites could be evaluated. The range of
differences in sizing between graft and pre-deploy-
ment aortic diameter varied from –3 mm to +7 mm,
equally distributed. The changes in the smallest diam-
eter and the surface of the aortic cross section at the
same level in the stent are given in Table I and II,
respectively. No correlation between aortic diameter
before and after stent graft deployment exists (r =
0.45; P = .37), because post-deployment diameter was
mainly influenced by the diameter of the percutaneous
transluminal angioplasty balloon.
The characteristics of atherosclerotic lesions did
not influence the change in diameter before and after
Table I. Descriptive statistics for both Gianturco and Palmaz stent grafts (in millimeters): the number of
stent grafts, minimal, maximal, and mean changes, and the standard deviation of the changes are given
No. of stent grafts Minimum Maximum Mean Standard deviation
G P G P G P G P G P
Pre-post 8 6 –4 –1 6 4 0 1 3 2
Pre-PTA 8 6 –3 1 6 1 1 1 3 —
Post-PTA 8 1 –1 0 4 0 1 0 2 —
G, Gianturco stent graft; P, Palmaz stent graft; pre-post, difference in aortic diameter before and after stent graft placement; pre-PTA,
before stent graft placement and after angioplasty; post-PTA, after stent graft placement and after angioplasty.
Table II. Descriptive statistics for both Gianturco and Palmaz stent grafts (in percentage): the number of
stent grafts, minimal, maximal, and mean changes, and the standard deviation of the changes are given
No. of stent grafts Minimum Maximum Mean Standard deviation
G P G P G P G P G P
Pre-post 8 6 –16 –5 40 22 4 5 18 10
Pre-PTA 8 6 –12 6 40 6 8 6 17 —
Post-PTA 8 1 –6 0 21 0 4 0 9 —
G, Gianturco stent graft; P, Palmaz stent graft; pre-post, difference in aortic diameter before and after stent graft placement; pre-PTA,
before stent graft placement and after angioplasty; post-PTA, after stent graft placement and after angioplasty.
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stent graft deployment. Evaluation results of the
stent attachment sites with IVUS and angioscopy
never revealed any folds. Both IVUS and angioscopy
correlated well in the detection of space between
stent graft and aorta (r = 0.94; P = .005). The size of
the space between stent graft and aortic wall visual-
ized with IVUS and the presence or absence of this
space during angioscopy significantly correlated with
the difference between diameter of the graft and the
aorta before stent graft deployment (r = -0.88; P =
.02; and r = -0.85; P = .03, respectively). The obser-
vation of aortic wall and stent graft during the heart
cycle revealed that the Palmaz stent, unlike the aorta,
did not expand in the systolic phase.
Again, in the case of closed side branches, no
endoleakage was seen. With open side branches,
endoleakage was seen in all the cases, but the grade
of endoleakage was significantly associated with the
difference between graft diameter and aortic diame-
ter that was measured directly after Palmaz stent
graft placement (Fig 6).
Angioplasty after stent graft insertion was per-
Fig 4. Relationship between biggest fold measured per
stent attachment site with intravascular ultrasound scan-
ning and difference between graft diameter and aortic
diameter at this stent attachment site directly after
Gianturco stent graft placement (actual oversizing).
Fig 2. Intended difference (in millimeters) between graft
and aortic diameter measured before stent graft placement
(pre) versus achieved undersizing or oversizing directly
after stent graft placement (post) and after angioplasty
(PTA) for both Gianturco and Palmaz stent grafts.
Fig 3. Relationship between atherosclerotic changes in
aortic wall, determined with computed tomography, and
change in aortic diameter between before and directly
after Gianturco stent graft placement.
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formed only at one stent attachment site. In this
case, a 16-mm graft was deployed with a 15-mm bal-
loon in an 18-mm aorta. After repeated angioplasty
with a 20-mm balloon, the aortic diameter was 19
mm. Graft-aortic interface improved as observed
with both IVUS and angioscopic results, but the
grade of endoleakage (grade 2) did not change.
Endoleakage in the Palmaz stent group varied from
grade 1 to 2 (mean, 1.3) and in the Gianturco stent
group from grade 1 to 4 (mean, 2.5).
DISCUSSION
Many clinicians use self-build stent grafts for the
treatment of abdominal aortic aneurysms. Most fre-
quently, these stent grafts are constructed with
either self-expandable Gianturco-Z stents or with
balloon-expandable Palmaz stents.7-10 Our evalua-
tion of these types of stent graft indicates that
“early” perigraft endoleakage is related to the type of
stent used and, in case of Gianturco stents, directly
to the amount of oversizing of the stent graft in rela-
tion with the aorta.
With the use of Gianturco stents, oversizing
leads to the formation of fabric folds. Both folding
and oversizing are significantly related to the grade
of endoleakage as visualized with DSA. In the case
of oversizing, the Z configuration of the 25-mm
Gianturco stent resulted in either folds with free
communication to the space between stent graft and
aorta or in folds that can be closed by the V-shape
between two struts at the distal end of the stent. In
the clinical situation, this only happens when the
length of the aortic neck exceeds 25 mm. In Figs 7
and 8, the result of 4-mm graft oversizing is shown
on a photograph and a IVUS image, respectively, in
case of the use of both Gianturco and Palmaz stent
for graft fixation. In the clinical situation, the
endoleakage through folds in the graft at the
Gianturco stent attachment sites may obliterate with
time by thrombosis of the endoleak. Although the
endoleak can no longer be visualized with imaging
techniques, pressure transmission through the
thrombus may still lead to elevated pressure in the
aneurysmal sac, with the possible risk of rupture.11
To reduce the size of the folds at the level of the
Gianturco stent, the oversizing of the graft as com-
pared with the aortic diameter has to be as little as
possible. Because of the fear for stent graft migration
as the result of aortic neck dilation at follow-up
examination, many clinicians advocate an oversizing
Fig 5. Relationship between biggest fold measured per
stent attachment site with intravascular ultrasound scan-
ning and grade of endoleakage with digital subraction
angiography directly after Gianturco stent graft placement.
Fig 6. Relation between grade of endoleakage and dif-
ference between graft diameter and aortic diameter mea-
sured directly after Palmaz stent graft placement (actual
oversizing).
Fig 7. Illustration of possible endoleak channels through
folds at Gianturco stent attachment site in case of 4-mm
graft oversizing (above). With use of Palmaz stent, folds
are absent (below).
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of at least 4 mm.10,12 However, this amount of over-
sizing may lead to endoleakage rather than sealing.
If we consider that the dilation of the graft material
occurs in time,13,14 ample oversizing with the use of
a self-expandable stent should not be necessary.
Lindh et al15 compared the hemostatic attachment
of Gianturco stent grafts and Palmaz stent grafts in
a mini pig aorta. With the use of Gianturco stents,
they noted longitudinal folds in the fabric at the
stent attachment site without leakage of blood.
Unfortunately, no information was given about the
difference between aortic and graft diameter, so a
comparison with our data is not possible.
If the Palmaz stents were used for graft fixation,
the folds were absent. The configuration of the
Palmaz stent results in a good approximation
between the graft and the aorta wall, unless the graft
is undersized. In the case of undersizing, space was
seen between the stent graft and the aortic wall. In
one case, the prosthesis was overdilated beyond the
diameter of the graft, leading to a satisfactory
approximation between the graft and aorta.
With the use of Palmaz stents, the accuracy of
stent graft sizing does not seem to be as important
when compared with the use of Gianturco stents.
The principle of “one size fits all” is supported by
our findings, except for graft undersizing. However,
during follow-up examination with aortic neck dila-
tion, the rigidity of the Palmaz stent will lead to
space between the aortic wall and the stent graft,16
possibly resulting in perigraft endoleakage and stent
graft migration.
The poor correlation between the diameter of
the aorta before and after Gianturco stent graft
placement is an unexpected finding in this study.
The self-expandable character of the Gianturco stent
appears to have an unpredictable effect on the aortic
diameter. In our experiments, this effect was related
to the extent of the atherosclerotic lesions in the aor-
tic wall, probably leading to a less compliant aorta.
This may explain the increase in diameter of the less
atherosclerotic aorta after Gianturco stent graft
placement, as compared with the diameter decrease
in cases of more severe atherosclerosis. These find-
ings suggest that oversizing of the stent graft will
sooner lead to endoleakage in an atherosclerotic
aorta than in a healthy aorta. The evaluation of the
aortic wall on atherosclerotic characteristics before
stent graft therapy can be important to decide which
graft diameter is the most optimal. The differences
between aorta wall characteristics in showing the
grade of calcification scored with IVUS, CT, and
clinical impression were small. So, both CT and
IVUS could be used for preoperative data collection
concerning atherosclerotic wall changes.
These study results provide unique angioscopic
information about the behavior of the stent graft in
relation to the aortic wall during circulation. During
angioscopy, the number of folds at the stent attach-
ment site was much more explicit as compared with
the IVUS image. Also, the pulsatile motion of aorta
and stent graft was much more evident than during
IVUS investigation. The Gianturco stent graft fol-
lowed the motion of the aortic wall closely during
the heart cycle. The folds tended to be smaller dur-
ing the systole phase than during the diastolic phase.
The Palmaz stent graft did not have any pulsatile
motion in circulation. This is in spite of the aortic
wall, which expanded beyond the diameter of the
Fig 8. Intravascular ultrasound scan image of Gianturco
stent graft (above) and Palmaz stent graft (below), both
with 4-mm oversizing as compared with aortic diameter
before stent graft placement. In case of Gianturco stent
graft, two large folds are present, whether Palmaz stent
graft has good interface with aortic wall.
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Palmaz stent even when the aorta had been overdi-
lated at stent graft insertion.
Angioscopy has been performed in an animal
model17,18 and in humans19 during endovascular
stent and stent graft therapy as a tool for optimal
placement of the proximal stent in relation to the
renal arteries. During these procedures with obstruc-
tion of circulation, visualization of a restricted aortic
segment through an inflated transparent balloon was
possible. However, for the visualization of the stent
attachment sites without compressing possible folds
against the aortic wall and for the observation of its
behavior during pulsatile flow, this technique is not
suitable during stent graft deployments in humans.
Because our study was performed in an in vitro sit-
uation, several comments can be made. The absence
of homeostasis and the use of water as perfusate will
exaggerate the amount of endoleakage seen during
the experiments and prohibit the spontaneous sealing
of endoleakage by thrombosis with time. The porosi-
ty of the graft material will cause endoleakage, even in
the absence of perigraft endoleaks. The grade 1
endoleakage can probably be explained by leakage
through the graft. If this is correct, most of the
Palmaz stent grafts were free of perigraft endoleakage,
in contrast to the Gianturco stent grafts.
Surprisingly, the angioplasty performed in the
presence of folds in the Gianturco stent graft did not
have any effect on the amount of endoleakage seen
with DSA. The only difference seen between the sit-
uation directly after stent graft placement and after
angioplasty was the change in number and size of the
folds. The folds tended to be larger in number and
smaller in size. In the clinical situation, an angioplas-
ty for endoleakage at the proximal Gianturco stent
attachment site will probably change less, as com-
pared with our in vitro results, in the situation before
angioplasty because of the hooks and barbs. These
hooks and barbs, which penetrate the aortic wall, will
prevent the redistribution of the stent graft over the
aortic surface. In our opinion, apart from correcting
angulation at a stent attachment site, the indication
for performing an angioplasty for perigraft endoleak-
age is questionable.
Geselschap et al6 demonstrated that the angula-
tion of non-coaxial IVUS imaging can lead to a sig-
nificant increase in the measured diameter. The use
of the smallest diameter of the aortic surface can
minimize this effect. This result of non-coaxial
IVUS imaging also has its repercussion on the sur-
face measurements. In our study, the diameter that
was calculated from the measured surface as if it
were a circle (surface = 1⁄2π[diameter]2) was only 0.3
mm on the average, which was larger than the small-
est measured diameter of the same aortic cross sec-
tion. This difference would not seriously influence
the ideal sizing of the stent graft. In our in vitro cir-
culation, the aortas did not have any significant
angulation, which sometimes exists in the clinical sit-
uation. Therefore, because of non-coaxial imaging,
the aortic diameter can be overestimated in the clin-
ical situation.
Many commercially available stent grafts use self-
expandable nitinol stents. The addition of these
stents to our experiment would have provided addi-
tional information, but unfortunately these stents
were not available to us.
In conclusion, we can state that, at the moment,
both stent/fabric combinations are not ideal for
immediate sealing after stent graft placement and
with follow-up for persistent stent graft/aortic con-
tact in dilating arterial segments. However, chang-
ing the Z shape of the self-expandable stent to a
shorter length might improve immediate sealing
with persistent aortic contact. Until the time that
this ideal stent graft is available, we will have to deal
with problems concerning sizing.
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